Automated Detection and Segmentation of Multiple Sclerosis Lesions Using Ultra-High-Field MP2RAGE.


Journal

Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 5 3 2019
medline: 7 1 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

The aim of this study was to develop a new automated segmentation method of white matter (WM) and cortical multiple sclerosis (MS) lesions visible on magnetization-prepared 2 inversion-contrast rapid gradient echo (MP2RAGE) images acquired at 7 T MRI. The proposed prototype (MSLAST [Multiple Sclerosis Lesion Analysis at Seven Tesla]) takes as input a single image contrast derived from the 7T MP2RAGE prototype sequence and is based on partial volume estimation and topological constraints. First, MSLAST performs a skull-strip of MP2RAGE images and computes tissue concentration maps for WM, gray matter (GM), and cerebrospinal fluid (CSF) using a partial volume model of tissues within each voxel. Second, MSLAST performs (1) connected-component analysis to GM and CSF concentration maps to classify small isolated components as MS lesions; (2) hole-filling in the WM concentration map to classify areas with low WM concentration surrounded by WM (ie, MS lesions); and (3) outlier rejection to the WM mask to improve the classification of small WM lesions. Third, MSLAST unifies the 3 maps obtained from 1, 2, and 3 processing steps to generate a global lesion mask. Quantitative and qualitative assessments were performed using MSLAST in 25 MS patients from 2 research centers. Overall, MSLAST detected a median of 71% of MS lesions, specifically 74% of WM and 58% of cortical lesions, when a minimum lesion size of 6 μL was considered. The median false-positive rate was 40%. When a 15 μL minimal lesions size was applied, which is the approximation of the minimal size recommended for 1.5/3 T images, the median detection rate was 80% for WM and 63% for cortical lesions, respectively, and the median false-positive rate was 33%. We observed high correlation between MSLAST and manual segmentations (Spearman rank correlation coefficient, ρ = 0.91), although MSLAST underestimated the total lesion volume (average difference of 1.1 mL), especially in patients with high lesion loads. MSLAST also showed good scan-rescan repeatability within the same session with an average absolute volume difference and F1 score of 0.38 ± 0.32 mL and 84%, respectively. We propose a new methodology to facilitate the segmentation of WM and cortical MS lesions at 7 T MRI, our approach uses a single MP2RAGE scan and may be of special interest to clinicians and researchers.

Identifiants

pubmed: 30829941
doi: 10.1097/RLI.0000000000000551
pmc: PMC6499666
mid: NIHMS1518257
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-364

Subventions

Organisme : Intramural NIH HHS
ID : ZIA NS003119-09
Pays : United States

Références

Neuroimage. 2009 Apr 1;45(2):333-41
pubmed: 19146961
Eur Radiol. 2010 Apr;20(4):915-22
pubmed: 19802613
IEEE Trans Med Imaging. 2016 May;35(5):1229-1239
pubmed: 26886978
J Magn Reson Imaging. 2016 Jun;43(6):1445-54
pubmed: 26606758
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):60-6
pubmed: 23813636
IEEE Trans Med Imaging. 2015 Jun;34(6):1349-61
pubmed: 25616008
Magn Reson Med. 2010 Jul;64(1):194-202
pubmed: 20572143
Med Image Anal. 2013 Jan;17(1):1-18
pubmed: 23084503
Ann Neurol. 2013 Nov;74(5):669-78
pubmed: 23813441
Neuroimage. 2017 Jul 15;155:159-168
pubmed: 28435096
PLoS One. 2013 Jul 16;8(7):e69294
pubmed: 23874936
Brain. 2015 Apr;138(Pt 4):932-45
pubmed: 25681411
Invest Radiol. 2012 Jun;47(6):346-52
pubmed: 22543966
Invest Radiol. 2017 May;52(5):265-273
pubmed: 27898603
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
IEEE Trans Med Imaging. 1997 Oct;16(5):598-609
pubmed: 9368115
Neuroimage Clin. 2015 May 16;8:367-75
pubmed: 26106562
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Eur Radiol. 2013 Feb;23(2):528-40
pubmed: 22898935
IEEE Trans Med Imaging. 1991;10(3):395-407
pubmed: 18222842
Neuroimage. 2010 Jan 15;49(2):1271-81
pubmed: 19819338
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neuroimage Clin. 2013 Jan 11;2:184-96
pubmed: 24179773
Neuroimage Clin. 2014 Nov 08;7:7-17
pubmed: 25429357
Brain. 2008 Sep;131(Pt 9):2332-40
pubmed: 18676439
Invest Radiol. 2009 Sep;44(9):491-4
pubmed: 19652606
Neurology. 2009 Sep 22;73(12):941-8
pubmed: 19641168
Ann Neurol. 2016 Nov;80(5):776-790
pubmed: 27686563
Neuroimage. 2010 Jan 15;49(2):1524-35
pubmed: 19766196
Brain. 2016 May;139(Pt 5):1472-81
pubmed: 26956422
AJNR Am J Neuroradiol. 2018 Mar;39(3):459-466
pubmed: 29439120
AJNR Am J Neuroradiol. 2015 Jul;36(7):1204-15
pubmed: 25523591
Med Image Comput Comput Assist Interv. 2014;17(Pt 1):771-8
pubmed: 25333189
Invest Radiol. 2016 Aug;51(8):469-82
pubmed: 26863580
Invest Radiol. 2014 May;49(5):290-8
pubmed: 24566291
AJNR Am J Neuroradiol. 2005 Mar;26(3):572-7
pubmed: 15760868
Neuroimage. 2017 Mar 1;148:77-102
pubmed: 28087490

Auteurs

Mário João Fartaria (MJ)

Department of Radiology, Centre Hospitalier Universitaire Vaudois.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, Lausanne.

Pascal Sati (P)

Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

Alexandra Todea (A)

Department of Radiology, Pourtalès Hospital, Neuchâtel.

Ernst-Wilhelm Radue (EW)

Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.

Reza Rahmanzadeh (R)

Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.

Kieran OʼBrien (K)

Centre for Advanced Imaging, University of Queensland.
Siemens Healthcare Pty Ltd, Brisbane, Queensland, Australia.

Daniel S Reich (DS)

Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

Meritxell Bach Cuadra (M)

Department of Radiology, Centre Hospitalier Universitaire Vaudois.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, Lausanne.
Medical Image Analysis Laboratory, Centre d'Imagerie BioMédicale, Lausanne.

Tobias Kober (T)

Department of Radiology, Centre Hospitalier Universitaire Vaudois.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, Lausanne.

Cristina Granziera (C)

Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
Translational Imaging in Neurology (ThINk) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel.
Department of Biomedical Engineering, University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH